心脏代谢危险因素对MASLD成人全因死亡风险的差异影响
基于NHANES III(1988-1994)和连续NHANES(1999-2018)数据,纳入21,872例FLI>60且至少一项CMRF的成人MASLD患者,随访至2019年。调整年龄、性别和FIB-4后,高血压、糖耐量异常和低HDL与全因死亡风险显著相关,BMI>35 kg/m2时风险随BMI升高而增加。
要点
- 高血压和糖耐量异常对MASLD患者全因死亡风险影响最大。
- BMI 35-40、40-45及>45 kg/m2较25-30 kg/m2死亡风险递增。
- CMRF数量每增加一项,全因死亡风险增加15%。
核心结论
- MASLD患者中不同CMRF对全因死亡风险的影响存在差异,高血压和糖耐量异常风险最高。
- 支持对CMRF进行优先级优化以改善预后。
研究设计与样本
- 基于NHANES III(1988-1994)和连续NHANES(1999-2018)的队列研究,随访至2019年。
- 纳入年龄>20岁、FLI>60且至少一项CMRF的成人,共21,872例,平均年龄50岁,53%男性。
- 采用Cox回归分析全因死亡风险,调整年龄、性别和FIB-4。
主要发现
- 平均BMI为33.6 kg/m2,中位CMRF数量为3项;99.5%超重/肥胖,55%糖耐量异常,58%高血压,67%高甘油三酯,40%低HDL。
- 高血压与全因死亡风险升高相关(aHR 1.39;95%CI 1.24-1.55;P<.001)。
- 糖耐量异常与全因死亡风险升高相关(aHR 1.26;95%CI 1.16-1.38;P<.01)。
- 低HDL与全因死亡风险升高相关(aHR 1.15;95%CI 1.05-1.26;P=.003)。
- 与BMI 25-30 kg/m2相比,BMI 35-40(aHR 1.18;95%CI 1.02-1.36;P=.03)、40-45(aHR 1.55;95%CI 1.24-1.94;P<.001)和>45 kg/m2(aHR 1.64;95%CI 1.27-2.14;P<.001)的全因死亡风险更高。
临床怎么用
- 在MASLD患者管理中,应优先评估和控制高血压与糖耐量异常。
- 对BMI≥35 kg/m2的MASLD患者,尤其是>40 kg/m2,需加强体重管理以降低死亡风险。
- CMRF数量可作为风险分层参考,每增加一项提示死亡风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by abnormalities in cardiometabolic risk factors (CMRFs). Characterizing the contribution of individual CMRFs to clinical outcomes may guide prioritization of interventions. We evaluated the association of individual CMRFs with all-cause mortality in United States adults with MASLD. METHODS: Participants in the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and continuous NHANES (1999-2018) were linked to mortality data through 2019. Adults >20 years of age were included if their Fatty Liver Index (FLI) was >60 and they had at least one CMRF (overweight/obesity, glucose intolerance, high blood pressure, triglycerides, or low high-density lipoprotein [HDL]). Cox regression analyzed risk of all-cause mortality adjusted for age, sex, and Fibrosis-4 (FIB-4). RESULTS: Among 21,872 participants included (mean age, 50 years; 53% male), the mean body mass index (BMI) was 33.6 kg/m2 with a median of 3 CMRF (99.5% overweight/obese, 55% glucose intolerance, 58% high blood pressure, 67% high triglycerides, 40% low HDL). In adjusted analysis of individual CMRF, high blood pressure (adjusted hazard ratio [aHR], 1.39; 95% confidence interval [CI], 1.24-1.55; P < .001), glucose intolerance (aHR, 1.26; 95% CI, 1.16-1.38; P < .01), and low HDL (aHR, 1.15; 95% CI, 1.05-1.26; P = .003) exerted significant risks for mortality. When stratifying the overweight/obesity CMRF by discrete BMI ranges, a significantly greater risk for mortality was seen with BMI 35 to 40 kg/m2 (aHR, 1.18; 95% CI, 1.02-1.36; P = .03), BMI 40 to 45 kg/m2 (aHR, 1.55; 95% CI, 1.24-1.94; P < .001), and BMI >45 kg/m2 (aHR, 1.64; 95% CI, 1.27-2.14; P < .001) compared with those with a BMI 25 to 30 kg/m2. In age-adjusted analysis, the number of CMRFs was associated with greater risk for mortality (aHR, 1.15 per additional CMRF; 95% CI, 1.10-1.20; P < .001) CONCLUSIONS: The differential risk for mortality between individual CMRFs supports distinct clinical profiles in MASLD. This study found that high blood pressure and glucose intolerance exerted the greatest risk for all-cause mortality in those with MASLD, suggesting a role for prioritization of CMRF optimization.
引用
- Dukewich M, Dodge JL, Yuan L, et al. Differential Effects of Cardiometabolic Risk Factors on All-Cause Mortality in United States Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Clin Gastroenterol Hepatol. 2025. PMID: 40972880. doi:10.1016/j.cgh.2025.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。